Eri Toda Kato

Learn More
BACKGROUND Elderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF-TIMI 48 trial, we evaluate clinical outcomes with edoxaban versus warfarin according to age. METHODS AND RESULTS Twenty-one thousand one-hundred and five patients enrolled(More)
  • 1